Doxorubicin HCl 0.4-mg/mL, Ondansetron HCl 0.48-mg/mL and Vincristine Sulfate 14-mcg/mL Injection

Author(s):  Allen Loyd V Jr

Issue:  Jul/Aug 2000 - Compounding for Hospice and Cancer Patients
View All Articles in Issue

Abstract:  A formulation for preparing Doxorubicin HCl 0.4-mg/mL, Ondansetron HCl 0.48-mg/mL and Vincristine Sulfate 14-mcg/mL Injection. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Categories: CANCER AND AIDS, FORMULATIONS, STABILITIES, COMPATIBILITIES

Purchase this article for download in electronic PDF format from IJPC at for $75 at:
https://ijpc.com/Abstracts/Abstract.cfm?ABS=503

Search the entire IJPC archive by keyword, topic, or issue at:
https://ijpc.com/Products